Cue Biopharma, Inc. insider trading
CUE$25.57+0.32 (+1.27%)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+18.5%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flowKey players
- SLShao-Lee Lin12.7244%
- SRSumita Ray2.1328%
- MVMichael Vincent Meluzio1.0497%
- DCDominique Christian Borie0.4336%
- PSPasha Sarraf0.4019%
- JMJames M. Ahlers0.351%
- VMViola Mong Meehan0.3001%
- DADaniel A. Camardo0.3001%
- PGPamela Garzone0.2602%
- DRDaniel R. Passeri0.0755%
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| CUE | Shao-Lee Lin | Open market sell$308K | -1.1% | $29.48 | $308K | Aug 13, 2026 | Aug 14, 2026 |
| CUE | Shao-Lee Lin | Open market sell$66.8K | -0.3% | $28.11 | $66.8K | Aug 13, 2026 | Aug 14, 2026 |
| CUE | Shao-Lee Lin | Open market sell$147K | -0.6% | $27.19 | $147K | Aug 13, 2026 | Aug 14, 2026 |
| CUE | Pasha Sarraf | Open market purchase$23.2K | +31.4% | $0.30 | $23.2K | Dec 30, 2025 | Jan 2, 2026 |
| CUE | Pasha Sarraf | Open market purchase$24.2K | +46.4% | $0.31 | $24.2K | Dec 30, 2025 | Jan 2, 2026 |
| CUE | Pasha Sarraf | Open market purchase$27.8K | +106.8% | $0.32 | $27.8K | Dec 30, 2025 | Jan 2, 2026 |
| CUE | Pasha Sarraf | Open market purchase$23.1K | +1824.3% | $0.30 | $23.1K | Dec 30, 2025 | Jan 2, 2026 |
| CUE | Pasha Sarraf | Open market purchase$1.31K | Not reported | $0.31 | $1.31K | Dec 30, 2025 | Jan 2, 2026 |